Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase - Implications for the Pim-1-mediated activation of the c-Myc signaling pathway

被引:211
作者
Mochizuki, T
Kitanaka, C
Noguchi, K
Muramatsu, T
Asai, A
Kuchino, Y
机构
[1] Natl Canc Ctr Res Inst, Div Biophys, Chuo Ku, Tokyo 1040045, Japan
[2] Univ Tokyo, Fac Med, Dept Neurosurg, Bunkyo Ku, Tokyo 1138655, Japan
[3] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan
关键词
D O I
10.1074/jbc.274.26.18659
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The pim-1 oncogene encodes a serine/threonine kinase (Pim-1) involved in the transduction of cytokine-triggered mitogenic signals. Pim-1 is unique in that it closely cooperates with c-Myc not only in oncogenesis, but also in apoptosis induction. However, the molecular basis of Pim-1 function remains poorly understood, largely because the downstream effector molecule(s) for Pim-1 kinase has not been identified. Here we provide several lines of evidence that Cdc25A cell cycle phosphatase, a direct transcriptional target for c-Myc, is a substrate for Pim-1 kinase and functions as an effector for Pim-1, We found that Pim-1 physically interacts with Cdc25A both in vitro and in vivo and phosphorylates Cdc25A. We also observed that Pim-1-mediated phosphorylation of Cdc25A increases its phosphatase activity. In addition, wild-type Pim-1, but not kinase-inactive Pim-1, enhanced Cdc25A-mediated cellular transformation and apoptosis, Our results indicate that Cdc25A might be a key molecule that links Pim-1 and c-Myc and that also ties Pim-1-mediated mitogenic signals to cell cycle machinery.
引用
收藏
页码:18659 / 18666
页数:8
相关论文
共 49 条
[1]  
ACTON D, 1992, MECH B CELL NEOPLASI, P293
[2]   THE HUMAN PROTOONCOGENE PRODUCT P33PIM IS EXPRESSED DURING FETAL HEMATOPOIESIS AND IN DIVERSE LEUKEMIAS [J].
AMSON, R ;
SIGAUX, F ;
PRZEDBORSKI, S ;
FLANDRIN, G ;
GIVOL, D ;
TELERMAN, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :8857-8861
[3]  
ASKEW DS, 1991, ONCOGENE, V6, P1915
[4]   VERY HIGH-FREQUENCY OF LYMPHOMA INDUCTION BY A CHEMICAL CARCINOGEN IN PIM-1 TRANSGENIC MICE [J].
BREUER, M ;
SLEBOS, R ;
VERBEEK, S ;
VANLOHUIZEN, M ;
WIENTJENS, E ;
BERNS, A .
NATURE, 1989, 340 (6228) :61-63
[5]   RAPID INDUCTION OF PIM-1 EXPRESSION BY PROLACTIN AND INTERLEUKIN-2 IN RAT NB2 LYMPHOMA-CELLS [J].
BUCKLEY, AR ;
BUCKLEY, DJ ;
LEFF, MA ;
HOOVER, DS ;
MAGNUSON, NS .
ENDOCRINOLOGY, 1995, 136 (12) :5252-5259
[6]  
CUYPERS HT, 1984, CELL, V37, P141
[7]  
DAUTRY F, 1988, J BIOL CHEM, V263, P17615
[8]  
DOMEN J, 1993, BLOOD, V82, P1445
[9]   PIM-1 LEVELS DETERMINE THE SIZE OF EARLY B-LYMPHOID COMPARTMENTS IN BONE-MARROW [J].
DOMEN, J ;
VANDERLUGT, NMT ;
ACTON, D ;
LAIRD, PW ;
LINDERS, K ;
BERNS, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) :1665-1673
[10]   THE CDC25 PROTEIN CONTAINS AN INTRINSIC PHOSPHATASE-ACTIVITY [J].
DUNPHY, WG ;
KUMAGAI, A .
CELL, 1991, 67 (01) :189-196